Risk-reducing removal of healthy mammary glands (risk-reducing bilateral mastectomy) significantly reduces the risk of BC and gives women with BRCA1 mutations a survival benefit [11, 12]; however, it also results in permanent loss of the breast and requires additional decisions regarding operations and breast reconstruction processes. The gene discussed is BRCA1; the disease is breast cancer.